VPS33B
Basic information
Region (hg38): 15:90998673-91022603
Links
Phenotypes
GenCC
Source:
- arthrogryposis, renal dysfunction, and cholestasis 1 (Definitive), mode of inheritance: AR
- arthrogryposis-renal dysfunction-cholestasis syndrome (Supportive), mode of inheritance: AR
- arthrogryposis, renal dysfunction, and cholestasis 1 (Strong), mode of inheritance: AR
- arthrogryposis, renal dysfunction, and cholestasis 1 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Keratoderma-ichthyosis-deafness syndrome, autosomal recessive; Cholestasis, progressive familial intrahepatic, 12; Arthrogryposis, renal dysfunction, and cholestasis 1 | AR | Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Renal | Individuals with Keratoderma-ichthyosis-deafness syndrome, autosomal recessive have been described with hearing impairment, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Cholestasis, progressive familial intrahepatic has been described as involving early-onset hepatic dysfunction, and medical and surgical interventions have been described as beneficial in some individuals; Individuals with Arthrogryposis, renal dysfunction, and cholestasis 1 may have manifstations including hearing loss, cardiovascular anomalies, renal dysfunction, and cholestasis, and awareness may allow early diagnosis and medical or surgical management of these sequelae | Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Gastrointestinal; Musculoskeletal; Renal | 28017832; 30561130; 31479177 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (15 variants)
- Arthrogryposis, renal dysfunction, and cholestasis 1 (11 variants)
- VPS33B-related disorder (1 variants)
- Cholestasis, progressive familial intrahepatic, 12 (1 variants)
- Keratoderma-ichthyosis-deafness syndrome, autosomal recessive (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS33B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 40 | 52 | ||||
missense | 116 | 120 | ||||
nonsense | 10 | 11 | ||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 1 | 2 | 9 | 13 | 1 | 26 |
non coding | 14 | 77 | 60 | 151 | ||
Total | 19 | 9 | 136 | 119 | 67 |
Highest pathogenic variant AF is 0.0000461
Variants in VPS33B
This is a list of pathogenic ClinVar variants found in the VPS33B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-90998713-A-C | Arthrogryposis, renal dysfunction, and cholestasis 1 | Uncertain significance (Jan 12, 2018) | ||
15-90998714-A-T | Arthrogryposis, renal dysfunction, and cholestasis 1 | Uncertain significance (Apr 27, 2017) | ||
15-90998820-T-C | Arthrogryposis, renal dysfunction, and cholestasis 1 | Uncertain significance (Jan 12, 2018) | ||
15-90998850-G-A | Arthrogryposis, renal dysfunction, and cholestasis 1 | Uncertain significance (Jan 12, 2018) | ||
15-90998862-C-T | Arthrogryposis, renal dysfunction, and cholestasis 1 | Uncertain significance (Jan 13, 2018) | ||
15-90998965-G-A | Arthrogryposis, renal dysfunction, and cholestasis 1 | Uncertain significance (Jan 12, 2018) | ||
15-90998978-G-A | Uncertain significance (Aug 15, 2017) | |||
15-90998988-TC-AG | Uncertain significance (Apr 07, 2022) | |||
15-90999009-C-T | Inborn genetic diseases | Uncertain significance (Apr 15, 2024) | ||
15-90999013-C-T | VPS33B-related disorder | Uncertain significance (Oct 04, 2023) | ||
15-90999014-G-A | Likely benign (Jun 28, 2017) | |||
15-90999015-C-T | Inborn genetic diseases | Uncertain significance (Jun 07, 2023) | ||
15-90999023-G-T | Likely benign (Feb 28, 2018) | |||
15-90999032-C-T | Likely benign (Jun 27, 2023) | |||
15-90999033-G-A | Inborn genetic diseases | Uncertain significance (Aug 15, 2023) | ||
15-90999047-C-T | Likely benign (Jul 17, 2023) | |||
15-90999049-T-C | Arthrogryposis, renal dysfunction, and cholestasis 1 • not specified | Conflicting classifications of pathogenicity (Feb 14, 2023) | ||
15-90999061-A-G | Likely benign (Jun 23, 2023) | |||
15-90999068-T-C | Arthrogryposis, renal dysfunction, and cholestasis 1 | Conflicting classifications of pathogenicity (Sep 01, 2023) | ||
15-90999107-C-T | Benign (Nov 12, 2018) | |||
15-90999183-G-GC | Likely benign (Jan 13, 2021) | |||
15-90999188-GC-G | Likely benign (Jan 13, 2021) | |||
15-90999251-GT-G | Benign (Nov 12, 2018) | |||
15-90999286-A-G | Benign (Jul 31, 2019) | |||
15-90999318-GT-G | Benign (Sep 04, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VPS33B | protein_coding | protein_coding | ENST00000333371 | 23 | 24188 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.41e-16 | 0.582 | 125653 | 0 | 95 | 125748 | 0.000378 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.364 | 314 | 333 | 0.944 | 0.0000205 | 4057 |
Missense in Polyphen | 99 | 113.1 | 0.87533 | 1287 | ||
Synonymous | 0.320 | 120 | 125 | 0.964 | 0.00000696 | 1149 |
Loss of Function | 1.76 | 31 | 43.5 | 0.712 | 0.00000282 | 477 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000792 | 0.000792 |
Ashkenazi Jewish | 0.000794 | 0.000794 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000387 | 0.000387 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000201 | 0.000196 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in vesicle-mediated protein trafficking to lysosomal compartments and in membrane docking/fusion reactions of late endosomes/lysosomes. Mediates phagolysosomal fusion in macrophages (PubMed:18474358). Proposed to be involved in endosomal maturation implicating VIPAS39. In epithelial cells, the VPS33B:VIPAS39 complex may play a role in the apical recycling pathway and in the maintenance of the apical-basolateral polarity (PubMed:20190753). Seems to be involved in the sorting of specific cargos from the trans-Golgi network to alpha-granule-destined multivesicular bodies (MVBs) promoting MVBs maturation in megakaryocytes (By similarity). {ECO:0000250|UniProtKB:P59016, ECO:0000269|PubMed:18474358, ECO:0000305|PubMed:20190753, ECO:0000305|PubMed:23918659}.;
- Disease
- DISEASE: Arthrogryposis, renal dysfunction and cholestasis syndrome 1 (ARCS1) [MIM:208085]: A multisystem disorder, characterized by neurogenic arthrogryposis multiplex congenita, renal tubular dysfunction and neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase activity. Platelet dysfunction is common. {ECO:0000269|PubMed:15052268, ECO:0000269|PubMed:18853461, ECO:0000269|PubMed:20190753, ECO:0000269|PubMed:22753090, ECO:0000269|PubMed:23918659}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.822
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.82
Haploinsufficiency Scores
- pHI
- 0.0591
- hipred
- Y
- hipred_score
- 0.516
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.789
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vps33b
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- vps33b
- Affected structure
- enterocyte
- Phenotype tag
- abnormal
- Phenotype quality
- dilated
Gene ontology
- Biological process
- vesicle docking involved in exocytosis;endosome organization;endosome to lysosome transport;protein transport;vesicle-mediated transport;peptidyl-lysine hydroxylation;melanosome localization;lysosome localization;collagen metabolic process;membrane fusion;platelet alpha granule organization;autophagosome maturation
- Cellular component
- cytoplasm;lysosome;lysosomal membrane;late endosome;Golgi apparatus;AP-3 adaptor complex;clathrin-coated vesicle;HOPS complex;platelet alpha granule;early endosome membrane;late endosome membrane;perinuclear region of cytoplasm;recycling endosome;clathrin complex
- Molecular function
- protein binding